Literature DB >> 21076884

Diffusion-weighted magnetic resonance imaging in focal breast lesions: analysis of 78 cases with pathological correlation.

F Fornasa1, L Pinali, A Gasparini, E Toniolli, S Montemezzi.   

Abstract

PURPOSE: This study assessed the usefulness of magnetic resonance diffusion-weighted imaging (DWI) in distinguishing between benign and malignant breast lesions.
MATERIALS AND METHODS: Gadolinium-enhanced magnetic resonance imaging (MRI) and DWI with determination of the apparent diffusion coefficient (ADC) were performed on 78 women, each with a focal breast lesion at least 7 mm in diameter, which was studied by cytology or histology.
RESULTS: Final diagnoses were obtained by cytology in 29 cases and histology in 49 (11 percutaneous biopsies and 38 surgical specimens). There were 43 benign lesions (13 fibrocystic disease, eight fibroadenoma, seven adenosis, five normal breast tissue, four inflammatory lesions, three intramammary lymph nodes, two scleroelastosis and one fat necrosis) and 35 malignant lesions (30 invasive ductal carcinoma, two invasive lobular carcinoma, one ductal carcinoma in situ, one carcinomatous mastitis and one metastasis from neuroendocrine carcinoma). The mean ADC values were 1.677±0.151 for benign lesions and 1.298±0.129 for malignant lesions (p<0.001). With an ADC cutoff value of 1.48, DWI had 88.6% sensitivity [confidence interval (CI) 78.1%-99.1%] and 95.3% specificity (CI 88.9%-100%), with 31 true positives, four false negatives (three invasive ductal carcinoma and one carcinomatous mastitis), 41 true negatives and two false positives (one fat necrosis and one fibroadenoma). With the cutoff value set at 1.52, DWI sensitivity (35 true positive, no false negative) was 100% and specificity was 86% (CI 75.7%-96.3%) due to 37 true negatives and six false positives (an additional two fibroadenoma and two fibrocystic disease compared with those recorded with the cutoff set at 1.48). The overall accuracy of DWI considering both cutoff values (72 correct evaluations out of 78 cases) was 92.3% (CI 86.4%-98.2%).
CONCLUSIONS: DWI is a reliable tool for characterising focal breast lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076884     DOI: 10.1007/s11547-010-0602-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  39 in total

1.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

Review 2.  Basic principles of diffusion-weighted imaging.

Authors:  Roland Bammer
Journal:  Eur J Radiol       Date:  2003-03       Impact factor: 3.528

3.  In vivo diffusion-weighted MRI of the breast: potential for lesion characterization.

Authors:  Shantanu Sinha; Flora Anne Lucas-Quesada; Usha Sinha; Nanette DeBruhl; Lawrence W Bassett
Journal:  J Magn Reson Imaging       Date:  2002-06       Impact factor: 4.813

4.  Quantitative diffusion imaging in breast cancer: a clinical prospective study.

Authors:  Erika Rubesova; Anne-Sophie Grell; Viviane De Maertelaer; Thierry Metens; Shih-Li Chao; Marc Lemort
Journal:  J Magn Reson Imaging       Date:  2006-08       Impact factor: 4.813

5.  Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.

Authors:  L Esserman; N Hylton; L Yassa; J Barclay; S Frankel; E Sickles
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

6.  Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis.

Authors:  P F Liu; J F Debatin; R F Caduff; G Kacl; E Garzoli; G P Krestin
Journal:  Br J Radiol       Date:  1998-05       Impact factor: 3.039

7.  Multifeature analysis of Gd-enhanced MR images of breast lesions.

Authors:  S Sinha; F A Lucas-Quesada; N D DeBruhl; J Sayre; D Farria; D P Gorczyca; L W Bassett
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

8.  MRI of occult breast carcinoma in a high-risk population.

Authors:  Elizabeth A Morris; Laura Liberman; Douglas J Ballon; Mark Robson; Andrea F Abramson; Alexandra Heerdt; D David Dershaw
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

9.  Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer.

Authors:  Miho I Yoshikawa; Shozo Ohsumi; Shigenori Sugata; Masaaki Kataoka; Shigemitsu Takashima; Teruhito Mochizuki; Hirohiko Ikura; Yutaka Imai
Journal:  Radiat Med       Date:  2008-05-29

10.  Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging.

Authors:  Seiko Kuroki-Suzuki; Yoshifumi Kuroki; Katsuhiro Nasu; Shigeru Nawano; Noriyuki Moriyama; Masatoshi Okazaki
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

View more
  18 in total

1.  Diagnosis of pericardial cysts using diffusion weighted magnetic resonance imaging: A case series.

Authors:  Asam Raja; Jonathon R Walker; Maneesh Sud; Joe Du; Matthew Zeglinski; Andrew Czarnecki; Negareh Mousavi; Davinder S Jassal; Iain Dc Kirkpatrick
Journal:  J Med Case Rep       Date:  2011-09-24

Review 2.  Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis.

Authors:  Monique D Dorrius; Hildebrand Dijkstra; Matthijs Oudkerk; Paul E Sijens
Journal:  Eur Radiol       Date:  2014-08-09       Impact factor: 5.315

3.  1H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.

Authors:  Stefania Montemezzi; Carlo Cavedon; Lucia Camera; Gabriele Meliadò; Francesca Caumo; Ilaria Baglio; Francesco Sardanelli
Journal:  Radiol Med       Date:  2016-12-15       Impact factor: 3.469

4.  Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis.

Authors:  Alexey Surov; Shuji Nagata; Ahmed A Abd Razek; Sree Harsha Tirumani; Andreas Wienke; Thomas Kahn
Journal:  Skeletal Radiol       Date:  2015-04-28       Impact factor: 2.199

Review 5.  Economic Benefits and Diagnostic Quality of Diffusion-Weighted Magnetic Resonance Imaging for Primary Lung Cancer.

Authors:  Katsuo Usuda; Aika Funazaki; Ryo Maeda; Atsushi Sekimura; Nozomu Motono; Munetaka Matoba; Hidetaka Uramoto
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-10-04       Impact factor: 1.520

6.  Comparison of fitting methods and b-value sampling strategies for intravoxel incoherent motion in breast cancer.

Authors:  Gene Young Cho; Linda Moy; Jeff L Zhang; Steven Baete; Riccardo Lattanzi; Melanie Moccaldi; James S Babb; Sungheon Kim; Daniel K Sodickson; Eric E Sigmund
Journal:  Magn Reson Med       Date:  2014-10-09       Impact factor: 4.668

7.  Diffusion-weighted Magnetic Resonance Imaging: What Makes Water Run Fast or Slow?

Authors:  Francesca Fornasa
Journal:  J Clin Imaging Sci       Date:  2011-05-19

Review 8.  Breast MR with special focus on DW-MRI and DCE-MRI.

Authors:  G Petralia; L Bonello; F Priolo; P Summers; M Bellomi
Journal:  Cancer Imaging       Date:  2011-06-28       Impact factor: 3.909

9.  How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient Ratio.

Authors:  Katsuo Usuda; Shun Iwai; Aika Yamagata; Yoshihito Iijima; Nozomu Motono; Mariko Doai; Munetaka Matoba; Keiya Hirata; Hidetaka Uramoto
Journal:  Clin Med Insights Oncol       Date:  2021-07-07

10.  Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast-conserving surgery-Results from a postmarketing study.

Authors:  Marc Thill; Iris Szwarcfiter; Katharina Kelling; Viviane van Haasteren; Eyal Kolka; Josefa Noelke; Zachi Peles; Moshe Papa; Sebastian Aulmann; Tanir Allweis
Journal:  J Surg Oncol       Date:  2021-11-01       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.